CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry | MicrobiomeTrials← Back to trialsNCT06100991
CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry
RecruitingOBSERVATIONAL
Trial Details
Start: 2023-09-19Est. Completion: 2099-12
Enrollment target: 200 participants Locations- CorEvitas, LLC, Waltham, Massachusetts, United States
Other microbiome trials you might be interested in
Generalized Pustular Psoriasis
This study is open to adults with a serious skin disease called generalized pustular psoriasis (GPP) who have repeated f…
Irvine, United StatesCompleted May 13, 2026
Palmoplantar Psoriasis
Palmoplantar psoriasis (PPPsO) is a type of psoriasis that affects the palms of hands and soles of the feet. It can caus…
Multiple LocationsEst. completion May 30, 2027